{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:23:22Z","timestamp":1764937402135,"version":"build-2065373602"},"reference-count":94,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ajg.2022.01.005","type":"journal-article","created":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T07:21:13Z","timestamp":1650698473000},"page":"125-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Update on hepatorenal Syndrome: Definition, Pathogenesis, and management"],"prefix":"10.1016","volume":"23","author":[{"given":"Elmukhtar","family":"Habas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman R.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moaz O.","family":"Moursi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bara A.","family":"Shraim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed E.","family":"Elgamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdel-Naser","family":"Elzouki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ajg.2022.01.005_b0005","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gin\u00e8s","year":"2009","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ajg.2022.01.005_b0010","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/MEG.0b013e328308bb9c","article-title":"Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality","volume":"21","author":"Cholongitas","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.ajg.2022.01.005_b0015","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1080\/03007995.2017.1331211","article-title":"The burden of hepatorenal syndrome among commercially insured and Medicare patients in the United States","volume":"33","author":"Rice","year":"2017","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"10.1016\/j.ajg.2022.01.005_b0020","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jhep.2007.02.001","article-title":"Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome","volume":"46","author":"Arroyo","year":"2007","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.ajg.2022.01.005_b0025","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jhep.2011.03.012","article-title":"Diagnosis, treatment and survival of patients with hepatorenal syndrome: a survey on daily medical practice","volume":"55","author":"Salerno","year":"2011","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.ajg.2022.01.005_b0030","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.ajg.2022.01.005_b0035","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","article-title":"Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis","volume":"63","author":"Bernardi","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajg.2022.01.005_b0040","unstructured":"Chales KFNg, Chan MHM, Tai MHL Lam CWK. Hepatorenal syndrome. Clin Biochem Rev 2007;28:11\u20137."},{"key":"10.1016\/j.ajg.2022.01.005_b0045","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/archsurg.1939.01200100028003","article-title":"Occurrence, distribution and pathogenesis of so called liver death and\/or hepatorenal syndrome","volume":"38","author":"Wilensky","year":"1939","journal-title":"Arch Surg"},{"issue":"1","key":"10.1016\/j.ajg.2022.01.005_b0050","first-page":"164","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2022.01.005_b0055","first-page":"1","article-title":"Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis","author":"Velez","year":"2020","journal-title":"Nephrology"},{"issue":"6","key":"10.1016\/j.ajg.2022.01.005_b0060","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajg.2022.01.005_b0065","first-page":"77","article-title":"Prognostic significance of renal dysfunction in cirrhosis","volume":"61","author":"Gines","year":"1997","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"10.1016\/j.ajg.2022.01.005_b0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Gin\u00e8s","year":"1993","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.ajg.2022.01.005_b0075","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cgh.2006.08.007","article-title":"Natural history of patients hospitalized for management of cirrhotic ascites","volume":"4","author":"Planas","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.ajg.2022.01.005_b0080","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/0016-5085(80)90793-3","article-title":"Lymph imbalance in the genesis and perpetuation of the ascites syndrome in hepatic cirrhosis","volume":"78","author":"Witte","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajg.2022.01.005_b0085","first-page":"520","article-title":"Renal sodium retention and ascites formation in dogs with experi-mental cirrhosis but without portal hypertension or increased splanchnic vascular capacity","volume":"91","author":"Levy","year":"1978","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.ajg.2022.01.005_b0090","unstructured":"Gattoni A, Marotta F, Vangieri B, Pisani G Cristiano F. Hepatorenal syndrome. Clin Ter 2004;155:375\u201389."},{"key":"10.1016\/j.ajg.2022.01.005_b0095","first-page":"1","article-title":"Hepatorenal syndrome questions & answers","author":"Devuni","year":"2017","journal-title":"Drug Dis Gastroenterol"},{"key":"10.1016\/j.ajg.2022.01.005_b0100","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.ajg.2022.01.005_b0105","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.cgh.2010.03.029","article-title":"Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites","volume":"8","author":"Montoliu","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.ajg.2022.01.005_b0110","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2010.03.021","article-title":"Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension","volume":"53","author":"Bosch","year":"2010","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.ajg.2022.01.005_b0115","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2010.03.021","article-title":"Hepatic endothelial dysfunction and ab-normal angiogenesis: new targets in the treatment of portal hypertension","volume":"53","author":"Bosch","year":"2010","journal-title":"J Hepatol"},{"issue":"01","key":"10.1016\/j.ajg.2022.01.005_b0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-0032-1301735","article-title":"Hepatorenal syndrome: a critical update","volume":"33","author":"Wadei","year":"2012","journal-title":"Semin Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ajg.2022.01.005_b0125","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0168-8278(05)80156-4","article-title":"Glucagon in portal hypertension","volume":"20","author":"Pak","year":"1994","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.ajg.2022.01.005_b0130","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0016-5085(86)91124-8","article-title":"Increased synthesis of systemic prostacyclin in cirrhotic patients","volume":"90","author":"Guarner","year":"1986","journal-title":"Gastroenterolo-Gy"},{"issue":"4","key":"10.1016\/j.ajg.2022.01.005_b0135","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00042737-200104000-00003","article-title":"Ascites and hepatorenal syndrome","volume":"13","author":"Gentilini","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.ajg.2022.01.005_b0140","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0168-8278(95)80292-4","article-title":"Endogenous factors involved in the control of arterial tone in cirrhosis","volume":"22","author":"Moreau","year":"1995","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.ajg.2022.01.005_b0145","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/hep.1840080207","article-title":"Endotoxin levels measured by a chromogenic as-say in portal, hepatic and peripheral venous blood in patients with cirrhosis","volume":"8","author":"Lumsden","year":"1988","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.ajg.2022.01.005_b0150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0168-8278(91)90810-X","article-title":"Regional sympathetic activity, severity of liver disease and hemodynamics in patients with cirrhosis","volume":"13","author":"Gaudin","year":"1991","journal-title":"J Hepatol"},{"issue":"01","key":"10.1016\/j.ajg.2022.01.005_b0155","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-2007-1007296","article-title":"Hepatorenal disorders: role of the sympathetic nervous system","volume":"14","author":"Henriksen","year":"1994","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.1016\/j.ajg.2022.01.005_b0160","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/hep.1840150622","article-title":"Adenosine receptor blockade reduces splanchnic hyperemia in cirrhotic rats","volume":"15","author":"Lee","year":"1992","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.ajg.2022.01.005_b0165","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1159\/000363584","article-title":"A pilot study to evaluate renal hemodynamics in cirrhosis by simultaneous glomerular filtration rate, renal plasma flow, renal resistive indices and biomarkers measurements","volume":"39","author":"Mindikoglu","year":"2014","journal-title":"Am J Nephrol"},{"issue":"7723","key":"10.1016\/j.ajg.2022.01.005_b0170","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0140-6736(71)90435-1","article-title":"Renal and intrarenal blood-flow in cirrhosis of the liver","volume":"298","author":"Kew","year":"1971","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ajg.2022.01.005_b0175","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9343(70)80073-0","article-title":"Renal failure in the patient with cirrhosis. The role of active vasoconstriction.; :1","volume":"49","author":"Epstein","year":"1970","journal-title":"Am J Med"},{"issue":"9398","key":"10.1016\/j.ajg.2022.01.005_b0180","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","article-title":"Hepatorenal syndrome","volume":"362","author":"Gin\u00e8s","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ajg.2022.01.005_b0185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semnephrol.2018.10.002","article-title":"Epidemiology, Pathophysiology, and Man-agement of Hepatorenal Syndrome","volume":"39","author":"Amin","year":"2019","journal-title":"Semin Nephrol"},{"issue":"01","key":"10.1016\/j.ajg.2022.01.005_b0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gut.2009.180570","article-title":"Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites","volume":"59","author":"Krag","year":"2010","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ajg.2022.01.005_b0195","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.ajg.2022.01.005_b0200","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/hep.21920","article-title":"Model for end-stage liver disease score and systemic in-flammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure","volume":"46","author":"Thabut","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2022.01.005_b0205","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.ajkd.2013.07.017","article-title":"Kidney Disease in the setting of liver failure: core curriculum 2013","volume":"62","author":"Thomas","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.ajg.2022.01.005_b0210","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/hep.26687","article-title":"Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival","volume":"59","author":"Barreto","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2022.01.005_b0215","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cgh.2016.07.016","article-title":"Terlipressin improves renal function and reverses hepatorenal syndrome in patients with systemic inflammatory response syndrome","volume":"15","author":"Wong","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.ajg.2022.01.005_b0220","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/0016-5085(91)90734-3","article-title":"Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor","volume":"101","author":"Lenz","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajg.2022.01.005_b0225","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/MCG.0b013e3181468b4c","article-title":"The molecules: mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension","volume":"41","author":"Iwakiri","year":"2007","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.ajg.2022.01.005_b0230","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.ajg.2022.01.005_b0235","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/BF02232870","article-title":"Impaired renal function exaggerates hyperbilirubinemia in bile duct-ligated dogs","volume":"15","author":"Fulop","year":"1970","journal-title":"Am J Dig Dis"},{"issue":"92","key":"10.1016\/j.ajg.2022.01.005_b0240","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5414\/CN109673","article-title":"Utility of a urine sediment score in hyperbilirubinemia\/hyperbilirubinuria","volume":"2019","author":"Poloni","year":"2019","journal-title":"Clin Nephrol."},{"issue":"1","key":"10.1016\/j.ajg.2022.01.005_b0245","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.23283","article-title":"Predictors of response to therapy with terlipressin and albu-min in patients with cirrhosis and type 1 hepatorenal syndrome","volume":"51","author":"Nazar","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.ajg.2022.01.005_b0250","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cgh.2017.05.041","article-title":"New developments in Hepatorenal Syndrome","volume":"16","author":"Mindikoglu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.ajg.2022.01.005_b0255","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/hep.26599","article-title":"Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice","volume":"58","author":"Fickert","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2022.01.005_b0260","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.4254\/wjh.v7.i8.1112","article-title":"Adrenal insufficiency in patients with decompensated cirrhosis","volume":"7","author":"Karagiannis","year":"2015","journal-title":"World J Hepatol"},{"issue":"5","key":"10.1016\/j.ajg.2022.01.005_b0265","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/hep.26535","article-title":"Relative adrenal insufficiency in decompensated cirrhosis: relationship to short-term risk of severe sepsis, hepatorenal syndrome, and death","volume":"58","author":"Acevedo","year":"2013","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.ajg.2022.01.005_b0270","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0016-5085(96)70068-9","article-title":"Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis","volume":"111","author":"Gines","year":"1996","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.ajg.2022.01.005_b0275","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cgh.2014.07.011","article-title":"Acute Liver Failure Study Group. Risk factors and outcomes of acute kidney injury in patients with acute liver failure","volume":"13","author":"Tujios","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.ajg.2022.01.005_b0280","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.kint.2017.04.048","article-title":"Acute kidney injury in acute-on-chronic liver failure: where does hepatorenal syndrome fit?","volume":"92","author":"Davenport","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajg.2022.01.005_b0285","first-page":"118","article-title":"Effect of renal dysfunction in fulminant hepatic failure","volume":"21","author":"Jain","year":"2000","journal-title":"Trop Gastroenterol"},{"issue":"5","key":"10.1016\/j.ajg.2022.01.005_b0290","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/CCM.0b013e318241e34e","article-title":"Angiopoietin-2 in acute liver failure","volume":"40","author":"Hadem","year":"2012","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.ajg.2022.01.005_b0295","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"CANONIC Study Investigators of the EASL\u2013CLIF Consortium. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ajg.2022.01.005_b0300","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.gastro.2014.05.005","article-title":"World Gastroenterology Organization Working Party. Toward an improved definition of acute-on-chronic liver failure","volume":"147","author":"Jalan","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajg.2022.01.005_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc11882","article-title":"Role of predisposition, injury, response and organ failure in the prognosis of patients with acute-on-chronic liver failure: a prospective cohort study","volume":"16","author":"Jalan","year":"2012","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.ajg.2022.01.005_b0310","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","article-title":"EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure","volume":"66","author":"Wendon","year":"2017","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.ajg.2022.01.005_b0315","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/gastro\/goab040","article-title":"Hepatorenal syndrome in acute-on-chronic liver failure with acute kidney injury: more questions requiring discussion","volume":"9","author":"Liu","year":"2021","journal-title":"Gastroenterol Rep"},{"issue":"4","key":"10.1016\/j.ajg.2022.01.005_b0320","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document","volume":"71","author":"Angeli","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajg.2022.01.005_b0325","doi-asserted-by":"crossref","first-page":"100236","DOI":"10.1016\/j.aohep.2020.07.008","article-title":"An integrated review of the hepatorenal syndrome","volume":"22","author":"Ojeda-Yuren","year":"2021","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.ajg.2022.01.005_b0330","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/gut.49.5.729","article-title":"The hepatorenal syndrome","volume":"49","author":"Dagher","year":"2001","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ajg.2022.01.005_b0335","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1590\/S1516-31802007000100010","article-title":"Hepatorenal Syndrome: an update","volume":"125","author":"Genzini","year":"2007","journal-title":"Sao Paulo Med J"},{"issue":"4","key":"10.1016\/j.ajg.2022.01.005_b0340","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.cld.2005.07.008","article-title":"Management of ascites in cirrhosis","volume":"9","author":"Sandhu","year":"2005","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.ajg.2022.01.005_b0345","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1053\/j.ajkd.2015.09.013","article-title":"Pathogenesis of hepatorenal syn-drome: implications for therapy","volume":"67","author":"Durand","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.ajg.2022.01.005_b0350","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/hep.30208","article-title":"Terlipressin is superior to noradrenaline in the management of acute kidney injury in acute on chronic liver failure","volume":"71","author":"Arora","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2022.01.005_b0355","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/apt.13912","article-title":"Systematic review with meta-analysis: vasoactive drugs for the treatment of hepoatorenal syndrome type 1","volume":"45","author":"Gifford","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ajg.2022.01.005_b0360","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/CEG.S153858","article-title":"Noradrenaline for reverting hepatorenal syndrome: a prospective, observational, single-center study","volume":"11","author":"Gupta","year":"2018","journal-title":"Clin Exp Gastroenterol"},{"issue":"1","key":"10.1016\/j.ajg.2022.01.005_b0365","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","article-title":"Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome","volume":"33","author":"Uriz","year":"2000","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.ajg.2022.01.005_b0370","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study","volume":"63","author":"Cavallin","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.ajg.2022.01.005_b0375","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","article-title":"Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study","volume":"36","author":"Duvoux","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2022.01.005_b0380","first-page":"30","article-title":"Noradrenaline is as effective as terlipressin in hepato-renal syndrome type 1: a prospective, randomized trial","volume":"64","author":"Goyal","year":"2016","journal-title":"J Assoc Physicians India"},{"issue":"5","key":"10.1016\/j.ajg.2022.01.005_b0385","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12664-018-0876-3","article-title":"Noradrenaline versus ter-lipressin in the management of type 1 hepatorenal syndrome: a randomized controlled study","volume":"37","author":"Saif","year":"2018","journal-title":"Indian J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ajg.2022.01.005_b0390","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000441151","article-title":"Hepatorenal acute kidney injury and the importance of raising mean arterial pressure","volume":"131","author":"Velez","year":"2015","journal-title":"Nephron"},{"issue":"9","key":"10.1016\/j.ajg.2022.01.005_b0395","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1111\/ajt.13790","article-title":"Protecting the kidney in liver transplant candidates: practice-based recommendations from the American Society of Transplantation Liver and Intestine Community of Practice","volume":"16","author":"O'Leary","year":"2016","journal-title":"Am J Transpl"},{"key":"10.1016\/j.ajg.2022.01.005_b0400","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.26359","article-title":"Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012","volume":"57","author":"Runyon","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2022.01.005_b0405","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long term outcome after transjugular intrahepatic por-tosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.ajg.2022.01.005_b0410","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis","volume":"123","author":"Gin\u00e8s","year":"2002","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ajg.2022.01.005_b0415","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ki.1979.8","article-title":"Effects of a portacaval or peritoneovenous shunt on renin in the hepatorenal syndrome","volume":"15","author":"Schroeder","year":"1979","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.ajg.2022.01.005_b0420","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hep.510280219","article-title":"Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems","volume":"28","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ajg.2022.01.005_b0425","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/hep.1840200306","article-title":"Impact of shunt surgery for variceal bleeding in the natural history of ascites in cirrhosis: a retrospective study","volume":"20","author":"Castells","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2022.01.005_b0430","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MEG.0b013e3283435d76","article-title":"Prevention of hepatorenal syn-drome in patients with cirrhosis and ascites: a pilot randomized control trial between pentoxi-fylline and placebo","volume":"23","author":"Tyagi","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.ajg.2022.01.005_b0435","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0168-8278(87)80569-X","article-title":"Effects of lumbar sympathetic block on kidney function in cirrhotic patients with hepatorenal syndrome","volume":"5","author":"Solis-Herruzo","year":"1987","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajg.2022.01.005_b0440","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1042\/cs0920433","article-title":"The hepatorenal syndrome","volume":"92","author":"Moore","year":"1997","journal-title":"Clin Sci"},{"issue":"3","key":"10.1016\/j.ajg.2022.01.005_b0445","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/lt.500060326","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial","volume":"6","author":"Mitzner","year":"2000","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.ajg.2022.01.005_b0450","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26185","article-title":"Extra-corporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial","volume":"57","author":"Ba\u00f1ares","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ajg.2022.01.005_b0455","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ki.1990.236","article-title":"Renal biopsy","volume":"38","author":"Madaio","year":"1990","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.ajg.2022.01.005_b0460","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/hep.27346","article-title":"Plasma protein biomarkers enhance the clinical prediction of kidney injury recovery in patients undergoing liver transplantation","volume":"60","author":"Levitsky","year":"2014","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.ajg.2022.01.005_b0465","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/TP.0b013e3182449161","article-title":"Evaluation of native kidney recovery after simultaneous liver-kidney transplantation","volume":"93","author":"Francis","year":"2012","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.ajg.2022.01.005_b0470","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ndt\/gfi212","article-title":"The course of type 1 hepato-renal syndrome post liver transplantation","volume":"21","author":"Marik","year":"2006","journal-title":"Nephrol Dial Transplant."}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197922000053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197922000053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:44:20Z","timestamp":1761659060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197922000053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1687197922000053"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2022.01.005","relation":{},"ISSN":["1687-1979"],"issn-type":[{"type":"print","value":"1687-1979"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on hepatorenal Syndrome: Definition, Pathogenesis, and management","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2022.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}